Solutions
Our Solutions
Deep, practical expertise in market access and evidence strategies for rare disease and innovative treatments
Delivering value in the global healthcare marketplace starts with the development of an innovation. To ensure new medicines and innovative technology reaches patients, the value messages and types of acceptable evidence for each healthcare stakeholder must be mapped, curated, and communicated.
Alkemi executes value assessments, evidence planning and value communications across the product lifecycle.
Our Process
Assess
Landscape
Build
Strategies & Evidence
Communicate
Value
Alkemi HEOR & Market Access Solutions Across the Product Lifecycle
Innovation
- Analogue Assessment
- Preliminary Value Story
- Reimbursement Assessment
- Literature Reviews (TLR, SLR)
- Early Pricing Models
Clinical
- Global Value Dossier
- HEOR Strategy
- Evidence Generation Plan
- PRO Selection / CRF Input
- Economic Models
Market Approval
- AMCP, HTA Dossier Formats
- Payer Value Deck
- Guidelines Evidence Positioning
- Research Collaborations
- Protocol Development
Post Market
- Clinical Guidelines Management & Updates
- Agency Comments
- Landscape Monitoring
- Publications / Strategy
- RWE Strategy
